Pharmacists are providing increasingly patient-centered clinical services such as Pharmacists Prescribing for Minor Ailments (PPMA). However, several factors delay pharmacists’ ability to implement PPMA including integration with workflow and time constrains. Technology solutions aim to support PPMA can be important innovative tools to help pharmacists to perform PPMA. The aim of this project is to examine the feasibility and potential impact of a new clinical innovative software tool to support pharmacists for minor ailment prescribing.
The purpose of this project is to design and evaluate a biofeedback device to help users to complete isometric shoulder and knee joint exercises. Specifically, the device, currently called the “Joint Force System (JFS)”, will measure the user’s force output and exercise form, and provide feedback to encourage ideal levels of effort and correct postures and joint motions. Through this project, the partner organization will gain access to state-of-the-art research facilities, literature, and experienced academic researchers to design and validate the device.
The current project aims to design and optimize the cryogenic CO2 capture process in terms of CO2 removal efficiency and energy requirement. The serious concern of global warming due to increasing CO2 emission has urged policymakers to employ various CO2 capture methods. Note that among different CO2 capture methods, the cryogenic capture is a favorable option since it uses less energy and no chemicals in the CO2 removal process. Cryogenic CO2 capture suffers from high equipment costs and energy consumption.
In tandem with increase in demand for lithium products for use in electric cars and electronics, there has been an interest in finding more sustainable lithium production processes as opposed to conventional evaporation ponds and hard rock mining both of which are environmentally intrusive and have high carbon footprint. Recion Technologies, Inc., an Edmonton based startup, has developed a sustainable direct lithium extraction process which can extract lithium from conventional and unconventional resource.
The project will focus on a new branch of metallurgy, SolvoMetallurgy to apply green and bio-degradable solvents for selective extraction of Platinum Group Metals (PGMs). The research will provide industry with a solution for sustainable extraction and near zero environmental impact of PGM extraction from secondary and primary resources. The proposed methodology will eliminate wastewater and toxic off-gassing in the process of PGM recycling while reducing the energy consumption and carbon footprint of PGM recycling/extraction production.
The aims of this research are to 1) assess mental health status and challenges longitudinally as veterinary students transition into working in the profession; and 2) develop a tool that is especially suitable to support positive mental health of early career veterinarians.
Questionnaires will be distributed to all Canadian veterinary undergraduate students in their final year and during their transition into the workplace to assess mental health status longitudinally. Individual one-on-one interviews with recent graduates will provide additional in-depth insights.
The annual economic impact of mental health illness and addiction on the Canadian economy is estimated to be around $50 billion, with projected increases in future years. Little research exists that has evaluated mental health illness and addictions in the Canadian workplace. The provision of counselling and therapy services helps to boost both mental health well-being and employment productivity, with gains well exceeding the cost of treatment itself.
This project aims to provide an alternative therapeutic for the prevention and treatment of the virus responsible for COVID-19, SARS-CoV-2, as well as respiratory syncytial virus and influenza. Using a single viral vector platform, we will deliver antibodies from human survivors of these diseases to provide sustained levels of protection against the virus for all patients, including the elderly and immunocompromised. This project will help Avamab Pharma Inc.
SeeO2 Energy has developed world-leading catalysts for reversible solid oxide fuel cell (RSOFC) systems with promising performance to produce syngas from H2O:CO2 feeds. The company has scaled-up the technology and has moved closer towards commercialization by building larger cells. However, assembling the RSOFC stack presents challenges due to issues associated with contact materials especially at the oxygen side of interconnects. The contact material connects the respective electrodes and interconnect and provides high electrical conduction paths between the interconnect and electrodes.
This project will pair together a academic Canadian research group with a pharmaceutical company who have developed a novel therapeutic (ALY688) to the stage that it will soon begin phase 1 clinical trials for the treatment of metabolic disease, such as diabetes. Since the success, and safety, of clinical trials requires accurate dosing of the new drug there is a need to develop a way to monitor the amount required to safely induce beneficial effects on the body. At the moment there is no assay which easily allows analysis of ALY688 action.
